Guru Ownership Trend
Guru Analysis for Theravance Biopharma, Inc. (TBPH)
Theravance Biopharma, Inc. (TBPH), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $5.15 M.
Top institutional holders include Renaissance Technologies (RenTech) and Paul Tudor Jones.
Institutional sentiment is currently Bullish. This is evidenced by a $1.35 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Paul Tudor Jones reduced exposure by 36.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Theravance Biopharma, Inc. (TBPH)
Major holders include Renaissance Technologies (RenTech) ($2.08 M), Paul Tudor Jones ($1.95 M), Joel Greenblatt ($733,791). According to the latest reported data, 4 tracked investment managers collectively hold approximately 320,607 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.35 M, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited TBPH. The total reported sell value was $1.14 M.
Yes, 1 managers opened new positions in TBPH, and 2 increased their existing holdings. The total reported buy value was $2.49 M.